(October 16, 2020, 10:21 AM EDT) -- ATLANTA — A federal judge in Georgia on Oct. 8 granted preliminary approval of a proposed settlement agreement in a shareholder derivative lawsuit brought on behalf of tissue graft maker MiMedx Group Inc. against several of the biopharmaceutical company’s current and former executive officers and directors that alleged that the defendants breached their fiduciary duty by covering up whistleblower allegations of a massive “channel-stuffing” scheme (In re MiMedx Group Inc. Shareholder Derivative Litigation, No. 18-4486, N.D. Ga.)....